1Senior Lecturer, Department of Oral and Maxillofacial Pathology, Jan Nayak Ch. Devi Lal Dental College, Sirsa, Haryana. India.
2Senior Lecturer, Department of Oral and Maxillofacial Pathology, Adesh Institute of Dental Sciences & research, Bathinda, Punjab, India.
3Senior Lecturer, Department of Oral and Maxillofacial Pathology, Swami Devi Dyal Hospital and Dental College, Panchkula, Haryana. India.
4PG Resident, Department of Oral and Maxillofacial Pathology, ITS Dental College Muradnagar, Ghaziabad, Uttar Pardesh, India.
Online published on 22 January, 2013.
Oral cancer is the most common head and neck cancer, found in 270,000 patients annually worldwide. Some cancers develop from precancerous lesions; however, there is no definitive clinico pathological factor or biomarker that reliably enables malignant transformation to be predicted in an individual patient. Early detection and early treatment of oral cancer are important for improving the survival rate of patients; prevention of oral cancer will clearly contribute most to decreasing its death rate. So correct diagnosis and timely treatment of premalignant lesions with high risk of malignant transformation may help to prevent malignant transformation.
Oral premalignant lesions, Potentially malignant lesions, Leukoplakia, Erythroplakia, Malignant transformation, Epithelial dysplasia
